HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M De Laurentiis Selected Research
M De Laurentiis Research Topics
Disease
26
Breast Neoplasms (Breast Cancer)
03/2024 - 01/2000
13
Neoplasms (Cancer)
01/2022 - 03/2000
4
Triple Negative Breast Neoplasms
12/2023 - 11/2010
3
Neoplasm Metastasis (Metastasis)
01/2019 - 01/2009
2
Obesity
03/2024 - 01/2016
2
Diarrhea
12/2022 - 04/2015
2
Nausea
12/2022 - 04/2015
2
Brain Neoplasms (Brain Tumor)
01/2021 - 01/2009
2
Prostatic Neoplasms (Prostate Cancer)
01/2005 - 11/2004
2
Colorectal Neoplasms (Colorectal Cancer)
03/2002 - 01/2002
1
Hypertriglyceridemia
03/2024
1
Pain (Aches)
12/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1
Inflammation (Inflammations)
10/2019
1
Cardiotoxicity
10/2019
1
Pathologic Complete Response
07/2018
1
Prediabetic State (Prediabetes)
01/2017
1
Insulin Resistance
01/2016
1
Wounds and Injuries (Trauma)
10/2015
1
Hypersensitivity (Allergy)
04/2015
1
Dysgeusia (Parageusia)
04/2015
1
Abdominal Pain (Pain, Abdominal)
04/2015
1
Alopecia (Baldness)
04/2015
1
Fatigue
04/2015
1
Vomiting
04/2015
1
Mucositis
04/2015
1
Overweight
08/2012
1
Circulating Neoplastic Cells
05/2012
1
Disease Progression
05/2005
1
Ovarian Neoplasms (Ovarian Cancer)
03/2002
1
Aneuploidy (Aneuploid)
09/2000
1
Kidney Neoplasms (Kidney Cancer)
09/2000
1
Renal Cell Carcinoma (Grawitz Tumor)
09/2000
Drug/Important Bio-Agent (IBA)
10
Hormones (Hormone)
IBA
01/2023 - 11/2010
6
Trastuzumab (Herceptin)
FDA Link
01/2021 - 05/2005
5
ErbB Receptors (EGF Receptor)
IBA
01/2023 - 06/2006
4
Fulvestrant (Faslodex)
FDA Link
01/2023 - 01/2021
3
ribociclib
IBA
01/2023 - 01/2021
2
Immune Checkpoint Inhibitors
IBA
12/2023 - 10/2019
2
Paclitaxel (Taxol)
FDA Link
Generic
04/2021 - 01/2021
2
Bevacizumab (Avastin)
FDA Link
04/2021 - 01/2021
2
eribulin
FDA Link
04/2021 - 01/2021
2
taxane
IBA
01/2021 - 05/2005
2
human ERBB2 protein
IBA
01/2021 - 01/2017
2
Estrogen Receptors
IBA
01/2021 - 12/2015
2
pembrolizumab
IBA
10/2019 - 01/2019
2
Letrozole (Femara)
FDA Link
Generic
07/2017 - 08/2012
2
Phenobarbital (Luminal)
FDA Link
01/2017 - 11/2010
2
Docetaxel (Taxotere)
FDA Link
04/2015 - 06/2006
2
Methotrexate (Mexate)
FDA Link
Generic
04/2015 - 01/2002
2
Fluorouracil (Carac)
FDA Link
Generic
04/2015 - 01/2002
2
Tamoxifen
FDA Link
Generic
08/2012 - 02/2005
2
Anthracyclines
IBA
11/2010 - 01/2000
1
hydroxide ion
IBA
03/2024
1
ORALIT (ORS)
IBA
03/2024
1
25-hydroxyvitamin D
IBA
03/2024
1
abemaciclib
IBA
12/2022
1
Cyclin-Dependent Kinase 4
IBA
12/2022
1
Ado-Trastuzumab Emtansine
IBA
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamide
IBA
01/2021
1
pertuzumab
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021
1
Interleukins
IBA
10/2019
1
NF-kappa B (NF-kB)
IBA
10/2019
1
Androgen Receptors (Androgen Receptor)
IBA
07/2018
1
Aromatase Inhibitors
IBA
07/2017
1
Progesterone
FDA Link
Generic
07/2017
1
Insulin (Novolin)
FDA Link
01/2016
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2015
1
Triptorelin Pamoate (Trelstar)
FDA Link
08/2012
1
Acids
IBA
08/2012
1
Zoledronic Acid (Zometa)
FDA Link
08/2012
1
Lapatinib (GW572016)
FDA Link
11/2010
1
Progesterone Receptors (Progesterone Receptor)
IBA
11/2010
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
11/2010
1
Epidermal Growth Factor (EGF)
IBA
11/2010
1
Taxoids (Taxanes)
IBA
11/2010
1
Gefitinib (Iressa)
FDA Link
06/2006
1
Tyrosine Kinase Inhibitors
IBA
06/2006
1
Goserelin (Zoladex)
FDA Link
02/2005
1
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2005
1
Androgens
IBA
01/2005
1
Biomarkers (Surrogate Marker)
IBA
01/2005
1
Complement System Proteins (Complement)
IBA
11/2004
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
03/2002
1
Topotecan (Hycamtin)
FDA Link
Generic
03/2002
1
Leucovorin (Folinic Acid)
FDA Link
01/2002
1
Proteins (Proteins, Gene)
FDA Link
09/2000
1
DNA (Deoxyribonucleic Acid)
IBA
09/2000
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
03/2000
1
Antisense Oligonucleotides
IBA
03/2000
Therapy/Procedure
15
Therapeutics
03/2024 - 11/2004
11
Drug Therapy (Chemotherapy)
03/2024 - 01/2002
2
Neoadjuvant Therapy
12/2023 - 07/2018
1
Immunotherapy
10/2019
1
Biological Therapy
10/2015
1
Radiotherapy
10/2015
1
Adjuvant Chemotherapy
04/2015
1
Prostatectomy (Retropubic Prostatectomy)
11/2004